For more than 20 years, the Division of Hematology has sustained a program of treatment and research in Cooley's anemia (thalassemia) with the aim of improving quality of life and increasing the life span of children with this disorder. Currently, approximately 60 patients with Cooley's anemia and other thalassemia syndromes are cared for at The Children's Hospital of Philadelphia.